Streetwise Articles

Medical Cannabis Innovator Set to Go Public
Source: Streetwise Reports  (8/18/17)
A licensed producer of medical cannabis in Canada will begin trading on the Canadian Securities Exchange on Aug. 21. More >

Brien Lundin

Six Precious Metal Explorers that May Hit It Big This Summer
Source: Streetwise Reports  (8/17/17)
Summer is the season for drilling, and with the uptick in the precious metals market since 2016, companies are finally able to have the budgets to properly explore their prospects, says Brien Lundin, editor of Gold Newsletter and organizer of the annual New Orleans Investment Conference. Positive results can mean a bump up in share prices, and Lundin discusses six companies that have been releasing good news this summer. More >

Canadian Explorer 'Definitely a Company Worth Watching'
Source: Streetwise Reports  (8/17/17)
As the drills turn in Quebec this summer, the results released by one explorer are gaining the attention of several experts. More >

Is the Next Gold Mine in Bulgaria?
Source: Streetwise Reports  (8/17/17)
While Bulgaria may not be the first country investors equate with gold mining, executives at one TSX Venture Exchange-listed company are sitting on pins and needles waiting for the drill results that could prove their high-grade thesis. More >

Michael Ballanger

A Midsummer Night's Dream: Buy Precious Metals
Source: Michael J. Ballanger for Streetwise Reports  (8/17/17)
Precious metals expert Michael Ballanger discusses the seasonality of gold and silver, and the metals' relationship with Bitcoin. More >

Adrian Day

Positive Drilling and Cash Flow at Favorite Companies
Source: Adrian Day for Streetwise Reports  (8/17/17)
Money manager Adrian Day discusses new developments at three of the miners in his portfolio. More >

Immunotherapy Company's Q2 Revenue 'Handily Beats' H.C. Wainwright's Projection
Source: Streetwise Reports  (8/16/17)
Analyst Ram Selvaraju with H.C. Wainwright & Co. provided an update on this biotech company's REVEAL clinical programs, as well as Q2/17 earnings that exceeded expectations.
More >

'Keep a Close Eye On' This Regenerative Medicine Firm
Source: Streetwise Reports  (8/16/17)
In an update on this company's clinical cell therapy programs targeting blood cancers and osteoarthritis in the knee, Gabrielle Zhou of Maxim Group describes progress that sets the stage for "value inflection."
More >

Maxim Raises Target Price of Biotech Company
Source: Streetwise Reports  (8/16/17)
A year-over-year increase in sales of its flagship product, and the prospect that its technology could be used to promote the efficacy of cell therapies, helped spur a target price increase on this biotech.
More >

A Critical Q&A with Nemaska Lithium CEO Guy Bourassa
Source: The Critical Investor for Streetwise Reports  (8/16/17)
The Critical Investor sits down with Nemaska Lithium CEO Guy Bourassa to discuss the company's latest financing, plant construction and mine development. More >

Adrian Day

Good News, Bad News and Encouraging News
Source: Adrian Day for Streetwise Reports  (8/16/17)
Money manager Adrian Day presents updates on three precious metal companies in his portfolio. More >


China, Gold and the US Dollar
Source: Clive Maund for Streetwise Reports  (8/15/17)
Clive Maund analyzes where the price of gold will go when China backs the yuan with it. More >

Silver Producer Moves Newly Acquired Argentinean Projects Forward
Source: Streetwise Reports  (8/15/17)
Andrew Kaip, an analyst with BMO Capital Markets, reviewed this senior mining company's Q2/17 financial highlights and project milestones.
More >

Bob Moriarty

Bet on the Jockey, not the Horse
Source: Bob Moriarty for Streetwise Reports  (8/15/17)
Bob Moriarty of 321 Gold explains why in some cases—and particularly in the case of this explorer—you don’t need to know all the details, you just need to know the geologist.
More >

Cryptocurrencies Exploding: This Is Nuts
Source: Tom Beck for Streetwise Reports  (8/15/17)
Cryptocurrencies are a megatrend, says Tom Beck, founder of Portfolio Wealth Global, and discusses their meteoric rise. More >

James Kwantes

11 Opportunities in Gold, Uranium and Diamonds
Source: Streetwise Reports  (8/14/17)
Former journalist James Kwantes, editor of Resource Opportunities, provides a tour of promising junior mining opportunities, from the extremes of northern Canada to the tropics of French Guiana. More >

Michael Ballanger

Fanciful Fed Follies
Source: Michael J. Ballanger for Streetwise Reports  (8/14/17)
Precious metals expert Michael Ballanger discusses the gold COT report and its implications for the metal. More >

Jack Chan

Jack Chan's Weekly Precious Metals Update
Source: Jack Chan for Streetwise Reports  (8/13/17)
Technical analyst Jack Chan charts the latest moves in the gold and silver markets. More >

Lior Gantz

North Korea Showdown: Pivotal Turning Point
Source: Lior Gantz for Streetwise Reports  (8/13/17)
The next two weeks could be a make-or-break period for President Trump, says Lior Gantz, founder of Wealth Research Group. More >

Adrian Day

Still Good Values Despite High Market
Source: Adrian Day for Streetwise Reports  (8/13/17)
Money manager Adrian Day updates developments at several companies in his portfolio. More >

Oil Company's First Well in Formation Delivers Strong Results
Source: Streetwise Reports  (8/10/17)
John White, an analyst with ROTH Capital Partners, provided initial well data and Q2/17 financial results for this Texas-based oil and natural gas explorer and producer. More >

Uranium Producer Seen as 'Top Leverage Pick to the Expected Uranium Price Recovery'
Source: Streetwise Reports  (8/10/17)
One uranium producer and explorer reported Q2/17 results that led one analyst to increase its target price. More >

Royalty Company Expects Strong Second Half After Another Solid Quarter
Source: Streetwise Reports  (8/10/17)
Andrew Kaip, an analyst with BMO Capital Markets, detailed this royalty company's Q2/17 financial results and relayed its expected production for the full year. More >

Cell Therapy for Melanoma Impresses in
Phase 2

Source: Streetwise Reports  (8/9/17)
Positive clinical data for this U.S. company's immunotherapy for metastatic melanoma are both encouraging and impressive, says one analyst.
More >

Over-the-Counter Treatments for Joint Pain and Women's Health Propel Company into New Markets
Source: Streetwise Reports  (8/9/17)
With the launch of its over-the-counter combination treatment for joint pain and new licensing agreements for feminine lubrication product Zestra, this San Diego-based company is expanding both its therapeutic and international reach.
More >

Showing Results: 1 to 25 of 14815 Next

Get Our Streetwise Reports Newsletter Free

A valid email address is required to subscribe